TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
50 hedge funds and large institutions have $111M invested in TCR2 Therapeutics Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
45% less capital invested
Capital invested by funds: $203M → $111M (-$91.9M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $109K
Holders
50
Holding in Top 10
2
Calls
–
Puts
$109K
Top Buyers
| 1 | +$719K | |
| 2 | +$635K | |
| 3 | +$610K | |
| 4 |
Renaissance Technologies
New York
|
+$397K |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$237K |
Top Sellers
| 1 | -$3.42M | |
| 2 | -$540K | |
| 3 | -$247K | |
| 4 |
Squarepoint
New York
|
-$199K |
| 5 |
Morgan Stanley
New York
|
-$121K |